UPDATE 2-U.S. FDA approves first two-drug HIV regimen in win for GSK By: Reuters: Company News November 22, 2017 at 03:46 AM EST * Two-drug approach differentiates GSK from Gilead (Adds context on GSK drive to improve pharma sales) Read More >> Related Stocks: Gilead Sciences Gsk Plc ADR Johnson & Johnson Pfizer
